Cargando…
Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit
Various clinical differences have been observed between patients with the FBN1 gene mutation and those with the classical Marfan phenotype. Although FBN1 knockout (KO) or dominant-negative mutant mice are widely used as an animal model for Marfan syndrome (MFS), these mice cannot recapitulate the ge...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963856/ https://www.ncbi.nlm.nih.gov/pubmed/29666143 http://dx.doi.org/10.1242/dmm.031542 |
_version_ | 1783325088413646848 |
---|---|
author | Chen, Mao Yao, Bing Yang, Qiangbing Deng, Jichao Song, Yuning Sui, Tingting Zhou, Lina Yao, HaoBing Xu, Yuanyuan Ouyang, Hongsheng Pang, Daxin Li, Zhanjun Lai, Liangxue |
author_facet | Chen, Mao Yao, Bing Yang, Qiangbing Deng, Jichao Song, Yuning Sui, Tingting Zhou, Lina Yao, HaoBing Xu, Yuanyuan Ouyang, Hongsheng Pang, Daxin Li, Zhanjun Lai, Liangxue |
author_sort | Chen, Mao |
collection | PubMed |
description | Various clinical differences have been observed between patients with the FBN1 gene mutation and those with the classical Marfan phenotype. Although FBN1 knockout (KO) or dominant-negative mutant mice are widely used as an animal model for Marfan syndrome (MFS), these mice cannot recapitulate the genotype/phenotype relationship of Marfanoid-progeroid-lipodystrophy (MPL) syndrome, which is caused by a mutation in the C-terminus of fibrillin-1, the penultimate exon of the FBN1 gene. Here, we describe the generation of a rabbit MPL model with C-terminal truncation of fibrillin-1 using a CRISPR/Cas9 system. FBN1 heterozygous (FBN1 Het) rabbits faithfully recapitulated the phenotypes of MFS, including muscle wasting and impaired connective tissue, ocular syndrome and aortic dilation. Moreover, skin symptoms, lipodystrophy, growth retardation and dysglycemia were also seen in these FBN1 Het rabbits, and have not been reported in other animal models. In conclusion, this novel rabbit model mimics the histopathological changes and functional defects of MPL syndrome, and could become a valuable model for studies of pathogenesis and drug screening for MPL syndrome. |
format | Online Article Text |
id | pubmed-5963856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59638562018-05-23 Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit Chen, Mao Yao, Bing Yang, Qiangbing Deng, Jichao Song, Yuning Sui, Tingting Zhou, Lina Yao, HaoBing Xu, Yuanyuan Ouyang, Hongsheng Pang, Daxin Li, Zhanjun Lai, Liangxue Dis Model Mech Resource Article Various clinical differences have been observed between patients with the FBN1 gene mutation and those with the classical Marfan phenotype. Although FBN1 knockout (KO) or dominant-negative mutant mice are widely used as an animal model for Marfan syndrome (MFS), these mice cannot recapitulate the genotype/phenotype relationship of Marfanoid-progeroid-lipodystrophy (MPL) syndrome, which is caused by a mutation in the C-terminus of fibrillin-1, the penultimate exon of the FBN1 gene. Here, we describe the generation of a rabbit MPL model with C-terminal truncation of fibrillin-1 using a CRISPR/Cas9 system. FBN1 heterozygous (FBN1 Het) rabbits faithfully recapitulated the phenotypes of MFS, including muscle wasting and impaired connective tissue, ocular syndrome and aortic dilation. Moreover, skin symptoms, lipodystrophy, growth retardation and dysglycemia were also seen in these FBN1 Het rabbits, and have not been reported in other animal models. In conclusion, this novel rabbit model mimics the histopathological changes and functional defects of MPL syndrome, and could become a valuable model for studies of pathogenesis and drug screening for MPL syndrome. The Company of Biologists Ltd 2018-04-01 2018-04-09 /pmc/articles/PMC5963856/ /pubmed/29666143 http://dx.doi.org/10.1242/dmm.031542 Text en © 2018. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/3.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | Resource Article Chen, Mao Yao, Bing Yang, Qiangbing Deng, Jichao Song, Yuning Sui, Tingting Zhou, Lina Yao, HaoBing Xu, Yuanyuan Ouyang, Hongsheng Pang, Daxin Li, Zhanjun Lai, Liangxue Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit |
title | Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit |
title_full | Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit |
title_fullStr | Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit |
title_full_unstemmed | Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit |
title_short | Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit |
title_sort | truncated c-terminus of fibrillin-1 induces marfanoid-progeroid-lipodystrophy (mpl) syndrome in rabbit |
topic | Resource Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963856/ https://www.ncbi.nlm.nih.gov/pubmed/29666143 http://dx.doi.org/10.1242/dmm.031542 |
work_keys_str_mv | AT chenmao truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT yaobing truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT yangqiangbing truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT dengjichao truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT songyuning truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT suitingting truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT zhoulina truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT yaohaobing truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT xuyuanyuan truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT ouyanghongsheng truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT pangdaxin truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT lizhanjun truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit AT lailiangxue truncatedcterminusoffibrillin1inducesmarfanoidprogeroidlipodystrophymplsyndromeinrabbit |